Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
Top Cited Papers
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 105 (5) , 917-922
- https://doi.org/10.1067/mai.2000.106040
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prevalence of allergic rhinitis in the United StatesJournal of Allergy and Clinical Immunology, 1997
- Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnairesJournal of Allergy and Clinical Immunology, 1997
- Treatment Strategies Designed to Minimize Medical Complications of Allergic RhinitisAmerican Journal of Rhinology, 1997
- Triamcinolone AcetonideDrugs, 1997
- Measuring health-related quality of life in rhinitis☆☆☆★Journal of Allergy and Clinical Immunology, 1997
- The role of leukotrienes in asthma and allergic rhinitisClinical and Experimental Allergy, 1996
- Treatment of Allergic RhinitisAnnals of Medicine, 1996
- Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4receptor antagonistCanadian Journal of Physiology and Pharmacology, 1995
- Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase InhibitorNew England Journal of Medicine, 1990
- Leukotrienes and Other Products of the 5-Lipoxygenase PathwayNew England Journal of Medicine, 1990